Project Grant HT94252310345
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$153K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...
The Defense Health Agency has awarded a $1,746,810 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Children's Hospital of Philadelphia (CHOP) Research Institute. The 3-year grant, effective July 1, 2025 through June 30, 2028, will support research on combination therapy for high-risk, MYCN-amplified neuroblastoma, a rare and aggressive form of pediatric cancer. CHOP, a renowned pediatric medical center and research institution, will...
The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
This $676,117 federal Project Grant award, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research initiatives conducted by The Children's Hospital of Philadelphia (CHOP) to transform healthcare for military service members and the general public. The grant funds research focused on expanded GAA-GGA chimeric repeats in Friedreich ataxia, a rare genetic neurological disorder. CHOP, a...
This $356,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a novel gene therapy for mitochondrial complex I deficiency at the Children's Hospital of Philadelphia (CHOP). The award period runs from March 1, 2024 to February 28, 2026. CHOP, a leading pediatric hospital and research institution, will leverage its expertise in areas like rare genetic disorders to advance this innovative...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,273,300 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in a mouse model of Friedreich's ataxia. The grant, with a performance period from September 1, 2024 to August 31, 2028, will support CHOP's pioneering research efforts to advance understanding and treatment of this...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,984,636 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in Friedreich's ataxia mice. The grant, awarded on September 1, 2024, will support this research project over a 4-year period until August 31, 2028. As a leading pediatric research institution, CHOP will leverage...
This $249,999 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program funds a research project to assess smoldering glial activation in pediatric-onset multiple sclerosis (MS) using novel neuroimaging techniques. The award recipient is the Childrens Hospital Medical Center in Cincinnati, Ohio, a prominent non-profit pediatric hospital and research center. The research aims to transform healthcare for...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $356,000 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "INTERROGATING CELL DEATH MECHANISMS AND IDENTIFYING THERAPEUTIC LEADS IN ZERBRAFISH AND HUMAN CELL SURF1 MODELS OF LEIGH SYNDROME." The research project aims to advance understanding of the cell death mechanisms involved in Leigh syndrome, a rare neurological disorder,...